Top stories
Marketing & MediaEx-TikTok and L’Oréal Luxe CMO Deshnie Govender launches culture Studio 545
Studio 545 1 day
PropertyRawson launches Business Brokers division as demand for business sales grows
Rawson Property Group 1 day
Trending
Subscribe & Follow
Advertise your job vacancies
Jobs
- Marketing AI Content Creator Internship Pretoria
- Graphic Designer & Content Creator Boksburg
Obesity Drug Linked to Suicidal Thoughts
The manufacturer of the antiobesity drug rimonobant, sold under the Acomplia brand, has informed the FDA that users of the medication suffer from a higher risk of suicidal thoughts. Sanofi-Aventis also told the FDA that it doesn't recommend the drug for people who suffer from depression.
Sanofi-Aventis has told the U.S. Food and Drug Administration its rimonobant antiobesity drug, also sold under the Acomplia brand, brings a higher risk of suicidal thoughts than placebo, and it does not recommend the treatment for patients suffering from major depression.
